データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Innocan Pharma Provides Its Annual "State of Research and Development" Update for 2024
Press Release: Innocan Pharma Reports Third Quarter 2024 Financial Results
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Innocan Pharma Engages Pain-Management Expert Ahead of FDA Meeting
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark